Re: Toy et al.: Chronic vascular arrest as a predictor of bevacizumab treatment failure in retinopathy of prematurity (Ophthalmology. 2016;123:2166-2175)

Ophthalmology. 2017 Jun;124(6):e52-e53. doi: 10.1016/j.ophtha.2016.12.028.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors
  • Bevacizumab*
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Intravitreal Injections
  • Retinopathy of Prematurity*
  • Treatment Failure
  • Vascular Endothelial Growth Factor A

Substances

  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A
  • Bevacizumab